Turning Point Brands Canada Becomes Exclusive Distributor for VPRB's HoneyStick in Canada

Business by 2FIRSTS.ai
Jan.09.2024
Turning Point Brands Canada Becomes Exclusive Distributor for VPRB's HoneyStick in Canada
VPR Brands announces Turning Point Brands Canada as the exclusive distributor of its HoneyStick products in Canada.

VPR Brands (OTC: VPRB) recently announced that Turning Point Brands Canada (TPB) will serve as the exclusive distributor for its HoneyStick products in Canada.

 

VPR Brands (VPRB) is an e-cigarette manufacturer dedicated to introducing innovative products.

 

TPB is a Canadian marketing and distribution company in the field of tobacco, e-cigarettes, and alternative products.

 

HoneyStick is set to join TPB Canada's portfolio of leading global brand management, alongside iconic brands such as Zig-Zag, Clipper, Choice Leaf, HMP, Rebound, and Evolve, to enter the Canadian market.

 

In the future, TPB Canada will streamline the retail process by centralizing ordering, logistics, and warehousing in one location. This will ensure a steady supply of HoneyStick products and reduce delivery times, enabling faster product delivery across Canada.

 

Currently, HoneyStick has launched on the Canadian e-commerce platform tpbmarketplace. However, it is either marked as "sold out" or yet to be available on several other Canadian e-commerce platforms.

 

Mikail Fancy, Chief Operating Officer of Turning Point Brands Canada, expressed enthusiasm over the partnership with VPR Brands to bring HoneyStick to a wider audience in Canada. Fancy highlighted the combination of their expertise in marketing, sales, distribution, and logistics, along with the quality and innovation of HoneyStick products, as a perfect match. He emphasized their commitment to providing excellent service and support for retailers and consumers.

 

Daniel Hoff, Chief Operating Officer of VPR Brands, has stated that the collaboration with Turning Point Brands Canada is a significant milestone for HoneyStick in Canada. Their strong distribution network and successful experience in marketing, sales, and customer service make them an ideal partner to enhance our brand's presence and accessibility nationwide.

 

VPR is currently involved in a significant case regarding a legal dispute with IMiracle (Heaven Gifts). The main point of contention revolves around the usage rights of the term "Elf" on e-cigarette products.

 

VPR filed a lawsuit in October 2022 against the distributor Shenzhen Weibo Li Technology Co., Ltd and the manufacturer iMiracle (HK) Limited, alleging infringement of VPR's trademark rights on ELF during the sales of Elfbar. Elfbar is the most popular disposable e-cigarette brand among young users.

 

In response, Judge Cannon in the United States issued a temporary injunction on Chinese companies in February 2023, prohibiting them from selling any e-cigarette products bearing the name ELFBAR. Judge Cannon stated that there is currently "no dispute" that these companies intentionally infringed upon VPR's trademark rights.

 

Shenzhen V-Perfect and iMiracle have submitted their first document claiming that they can prove V-Perfect is not the original user of the ELF trademark. According to the documents submitted by these two companies on April 24th, they have discovered the true owner of the ELF trademark, another Chinese company called GD Sigelei Electronic Tech. This company first used the "ELF" to sell e-cigarette products in April 2016, almost a year and a half earlier than V-Perfect's first batch of ELF products.

 

In March of this year, two Chinese companies signed a trademark transfer agreement, claiming to have transferred the rights to the Elf trademark to iMiracle. Based on this, they have requested Judge Cannon to revoke the temporary injunction.

 

Another important document claims that VPR has utilized a court order prohibiting them from manufacturing ELFBAR in order to seek market share. According to the document from May, VPR has launched a "blatantly imitated" ELFBAR disposable e-cigarette, clearly copying iMiracle's product. Both of these Chinese companies argue that these inferior counterfeit products will confuse consumers, ultimately leading to ELFBAR losing market share and reputation.

 

Although both parties have informed the mediators that Judge Cannon's decision on these two motions will "guide their positions for settlement," the case remains at a standstill, waiting for the Chinese companies to appeal to the Federal Circuit in an attempt to overturn the injunction. These two Chinese companies are dissatisfied with the temporary ban and stated in their submission to the Federal Circuit that the injunction is erroneous and has resulted in them losing millions of dollars.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
France’s top health agency has confirmed that vaping is less harmful than smoking — but not risk-free — reshaping the country’s regulatory trajectory. As Paris withdraws a proposed vape tax and debates stricter ingredient, emissions and youth-protection rules, the ANSES report signals not prohibition, but tighter technical oversight. For manufacturers, retailers and EU policymakers, France may be previewing Europe’s next phase of nicotine governance.
Special Report
Feb.23
South Korea Postal Service Launches Heated Tobacco Device Recycling Program Through Nationwide Post Offices and Mailboxes
South Korea Postal Service Launches Heated Tobacco Device Recycling Program Through Nationwide Post Offices and Mailboxes
Korean postal system launches nationwide heated tobacco device recycling through post offices and mailboxes, aiming to increase recycling rates.
Feb.10 by 2FIRSTS.ai
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.
Feb.27 by 2FIRSTS.ai
Azerbaijan’s Milli Majlis to hold public hearings on e-cigarette use in the 2026 spring session
Azerbaijan’s Milli Majlis to hold public hearings on e-cigarette use in the 2026 spring session
Azerbaijan’s Milli Majlis will hold public hearings regarding the use of e-cigarettes. The topic has been included in the 2026 spring session work plan of the Milli Majlis Committee on Agrarian Policy. During the spring session, the committee plans to convene a public hearing titled “Health is our goal: an end to e-cigarettes.”
Jan.23 by 2FIRSTS.ai
Alabama House Health Committee advances SB9 to restrict vaping in public spaces under Clean Indoor Air Act
Alabama House Health Committee advances SB9 to restrict vaping in public spaces under Clean Indoor Air Act
The Alabama House Health Committee passed Senate Bill 9 on Wednesday to restrict vaping in public areas under the state’s Clean Indoor Air Act. Introduced by Sen. Gerald Allen, SB9 would add vapes—defined as “electronic nicotine delivery systems”—to the forms of “smoking” currently prohibited in enclosed public places.
Feb.13 by 2FIRSTS.ai
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02